Severe acute respiratory syndrome coronavirus on hospital surfaces

被引:128
作者
Dowell, SF
Simmerman, JM
Erdman, DD
Wu, JSJ
Chaovavanich, A
Javadi, M
Yang, JY
Anderson, LJ
Tong, SX
Ho, MS
机构
[1] Minist Publ Hlth, Dept Dis Control, Int Emerging Infect Program, Nonthaburi 11000, Thailand
[2] Ctr Dis Control & Prevent, Int Emerging Infect Program, Atlanta, GA USA
[3] Ctr Dis Control & Prevent, Resp & Enter Viruses Branch, Div Viral & Rickettsial Dis, Atlanta, GA USA
[4] Ctr Dis Control, Taipei, Taiwan
[5] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan
关键词
D O I
10.1086/422652
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Health care workers continued to contract severe acute respiratory syndrome (SARS), even after barrier precautions were widely implemented. Methods. We explored the possible contribution of contaminated hospital surfaces to SARS transmission by swabbing surfaces in 2 hospitals and testing the swab samples by reverse-transcriptase polymerase chain reaction (RT-PCR) and viral culture. Results. Twenty-six of 94 swab samples tested positive for viral RNA. Swab samples of respiratory secretions from each of the 4 patients examined tested positive by RT-PCR, as were 12 of 43 swabs from patient rooms and 10 of 47 swabs from other parts of the hospital, including the computer mouses at 2 nursing stations and the handrail of the public elevator. Specimens from areas with patients with SARS in the most infectious phase of illness (days 5-15 after onset) were more likely to be RNA positive than were swab specimens from elsewhere (24 of 63 samples vs. 2 of 31 samples; P=.001). All cultures showed no growth. Conclusions. Although the viruses identified may have been noninfectious, health care workers should be aware that SARS coronavirus can contaminate environmental surfaces in the hospital, and fomites should be considered to be a possible mode of transmission of SARS.
引用
收藏
页码:652 / 657
页数:6
相关论文
共 17 条
[1]  
[Anonymous], 2013, WHOCDSCSRGAR2003
[2]  
*CDCP, 2003, MMWR-MORBID MORTAL W, V52, P241
[3]  
*CDCP, 2003, MMWR-MORBID MORTAL W, V52, P433
[4]  
Centers for Disease Control and Prevention, 2003, MMWR-MORBID MORTAL W, V52, P1
[5]  
Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P248
[6]  
Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P461
[7]   Real-time reverse transcription-polymerase chain reaction assay for SARS-associated coronavirus [J].
Emery, SL ;
Erdman, DD ;
Bowen, MD ;
Newton, BR ;
Winchell, JM ;
Meyer, RF ;
Tong, SX ;
Cook, BT ;
Holloway, BP ;
McCaustland, KA ;
Rota, PA ;
Bankamp, B ;
Lowe, LE ;
Ksiazek, TG ;
Bellini, WJ ;
Anderson, LJ .
EMERGING INFECTIOUS DISEASES, 2004, 10 (02) :311-316
[8]   SURVIVAL CHARACTERISTICS OF AIRBORNE HUMAN CORONAVIRUS-229E [J].
IJAZ, MK ;
BRUNNER, AH ;
SATTAR, SA ;
NAIR, RC ;
JOHNSONLUSSENBURG, CM .
JOURNAL OF GENERAL VIROLOGY, 1985, 66 :2743-2748
[9]   A novel coronavirus associated with severe acute respiratory syndrome [J].
Ksiazek, TG ;
Erdman, D ;
Goldsmith, CS ;
Zaki, SR ;
Peret, T ;
Emery, S ;
Tong, SX ;
Urbani, C ;
Comer, JA ;
Lim, W ;
Rollin, PE ;
Dowell, SF ;
Ling, AE ;
Humphrey, CD ;
Shieh, WJ ;
Guarner, J ;
Paddock, CD ;
Rota, P ;
Fields, B ;
DeRisi, J ;
Yang, JY ;
Cox, N ;
Hughes, JM ;
LeDuc, JW ;
Bellini, WJ ;
Anderson, LJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (20) :1953-1966
[10]   The SARS epidemic in Hong Kong [J].
Lee, SH .
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2003, 57 (09) :652-654